Clinical trial
S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With…
NCT00064038 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00064038 |
|---|---|
| Title | S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma |
| Official title | Phase III Trial Comparing Dexamethasone (DEX) to the Combination of DEX + CC-5013 in Patients With Previously Untreated Multiple Myeloma |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma, Plasma Cell Neoplasm |
| Intervention type | Drug, Other |
| Interventions | dexamethasone, lenalidomide, placebo |
| Enrollment | 198 |
| Start date | Nov 1, 2004 |
| Primary completion | Oct 1, 2008 |
| Completion | May 1, 2012 |
| First posted | Jul 9, 2003 |
| Last update posted | Mar 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: